Skip to content
value.today

Cynvenio Biosystems LLC

Total raised
$57 M
11 rounds on record
Latest round
$1 M
Jul 2021
First round on record
May 2009
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cynvenio Biosystems LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2021$1 MNo. 11Under $2 million

Cynvenio Biosystems LLC: Raise no. 11, Jul 2021

Investors in this round

2 investors had bought by the notice of Jul 16, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Anderson · Executive Officer, Director
  • Paul Pagano · Executive Officer, Director
  • Andrew Roy Boteler · Director
  • Gordon Roy Davis · Director
  • James McCullough · Director
  • Sara Roy Barrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Pagano, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Jul 16, 2021. Read the notice at the SEC.

equitySEC
Jul 2021$3 MNo. 10$2 to $10 million

Cynvenio Biosystems LLC: Raise no. 10, Jul 2021

Investors in this round

2 investors had bought by the notice of Jul 15, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Anderson · Executive Officer, Director
  • Paul Pagano · Executive Officer, Director
  • Gordon Roy Davis · Director
  • James McCullough · Director
  • Sara Roy Barrington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Pagano, Ceo. Source: SEC Form D, newest notice filed Jul 15, 2021. Read the notice at the SEC.

optionsSEC
Oct 2017$10 MNo. 9$10 to $50 million

Cynvenio Biosystems LLC: Raise no. 9, Oct 2017

Investors in this round

35 investors had bought by the notice of May 26, 2021: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $12 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Secured Promissory Note; Warrant
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Anderson · Executive Officer · Chief Financial Officer
  • Michael Pfau · Executive Officer · Secretary
  • Paul Pagano · Executive Officer, Director · Chief Executive Officer
  • Frederick Gluck · Director
  • James McCullough · Director
  • Jianing Liu · Director
  • Justin Xiang · Director
  • Simon Raab · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Pagano, Ceo. Source: SEC Form D and 8 amendments, newest notice filed May 26, 2021. Read the notice at the SEC.

debt, optionsSEC
May 2015$25 MNo. 8$10 to $50 million

Cynvenio Biosystems LLC: Raise no. 8, May 2015

Investors in this round

41 investors had bought by the notice of Jun 4, 2015: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them, other: Note Conversion and Series B Preferred Stock Agreement
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer, Director · Chief Executive Officer
  • Michael de Pfau · Executive Officer · Secretary
  • Alan de Heeger · Director
  • Daotian de Fu, Ph.D · Director
  • Frederick de Gluck · Director
  • Paul de Billings · Director
  • Simon de Raab · Director
  • YuCai de Peng, Ph.D · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds will be used for working capital by the Company.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D, newest notice filed Jun 4, 2015. Read the notice at the SEC.

equitySEC
Jul 2014$3 MNo. 7$2 to $10 million

Cynvenio Biosystems LLC: Raise no. 7, Jul 2014

Investors in this round

23 investors had bought by the notice of Sep 2, 2014: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Secured Note and Warrant
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre De Fusco · Executive Officer, Director · Chief Executive Officer
  • Michael Pfau · Executive Officer · Secretary
  • Alan Heeger · Director
  • Frederick Gluck · Director
  • Simon Raab · Director
  • Tom Hyongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds used for working capital.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Sep 2, 2014. Read the notice at the SEC.

debt, optionsSEC
Nov 2013$1 MNo. 6Under $2 million

Cynvenio Biosystems LLC: Raise no. 6, Nov 2013

Investors in this round

3 investors had bought by the notice of Jan 28, 2014: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B-4 Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer, Director · Chief Executive Officer
  • Michael Pfau · Executive Officer · Secretary
  • Alan Heeger · Director
  • Amit Munshi · Director
  • Frederick Gluck · Director
  • Simon Raab · Director
  • Tom Hyongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds used for working capital.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jan 28, 2014. Read the notice at the SEC.

equitySEC
Jun 2013$3 MNo. 5$2 to $10 million

Cynvenio Biosystems LLC: Raise no. 5, Jun 2013

Investors in this round

2 investors had bought by the notice of Oct 18, 2013: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Note and Warrant offering
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer, Director · Chief Executive Officer
  • Michael Pfau · Executive Officer · Secretary
  • Alan Heeger · Director
  • Amit Munshi · Director
  • Frederick Gluck · Director
  • Simon Raab · Director
  • Tom Hyongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds to be used for working capital.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 4 amendments, newest notice filed Oct 18, 2013. Read the notice at the SEC.

debt, optionsSEC
Jun 2012$3 MNo. 4$2 to $10 million

Cynvenio Biosystems LLC: Raise no. 4, Jun 2012

Investors in this round

15 investors had bought by the notice of Nov 26, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Series B-4 Preferred Stock and Warrant
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer, Director · Chief Executive Officer and President
  • Michael Pfau · Executive Officer · Secretary
  • Paul Meyer · Executive Officer · Chief Financial Officer
  • Alan Heeger · Director
  • Amit Munshi · Director
  • Frederick Gluck · Director
  • Harry Gelles · Director
  • Simon Raab · Director
  • Tom Hyhongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds used for working capital.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 3 amendments, newest notice filed Nov 26, 2012. Read the notice at the SEC.

equity, optionsSEC
Nov 2011$3 MNo. 3$2 to $10 million

Cynvenio Biosystems LLC: Raise no. 3, Nov 2011

Investors in this round

25 investors had bought by the notice of May 7, 2012: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Note and Warrant Offering
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer, Director · President and Chief Executive Officer
  • Michael Pfau · Executive Officer · Secretary
  • Paul Meyer · Executive Officer · Chief Financial Officer
  • Alan Heeger · Director
  • Amit Munshi · Director
  • Frederick Gluck · Director
  • Simon Raab · Director
  • Tom Hyongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds to be used for working capital.”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed May 7, 2012. Read the notice at the SEC.

debt, optionsSEC
Aug 2010$2 MNo. 2Under $2 million

Cynvenio Biosystems LLC: Raise no. 2, Aug 2010

Investors in this round

1 investor had bought by the notice of May 24, 2011: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, other: Convertible Note and Warrant Offering
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre Fusco · Executive Officer, Director · President
  • Michael Pfau · Executive Officer · Secretary
  • Paul Meyer · Executive Officer · Chief Financial Officer
  • Alan Heeger · Director
  • Frederick Gluck · Director
  • Harry Gelles · Director
  • Tom Hyongsok Soh · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Proceeds to be used for working capital”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 2 amendments, newest notice filed May 24, 2011. Read the notice at the SEC.

debt, optionsSEC
May 2009$2 MNo. 1Under $2 million

Cynvenio Biosystems LLC: Raise no. 1, May 2009

Investors in this round

1 investor had bought by the notice of Jan 11, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B Preferred Stock
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Andre de Fusco · Executive Officer · President and Manager
  • Michael E. Pfau · Executive Officer · Secretary

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for working capital”

Signed by Michael E. Pfau, Secretary. Source: SEC Form D and 6 amendments, newest notice filed Jan 11, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cynvenio Biosystems LLC chose not to state its revenue in its newest notice of a funding round (Jul 2021).

    SEC Form D · Jul 2021

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jul 2021

That is all the official record says: Cynvenio Biosystems LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cynvenio Biosystems LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 41 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cynvenio Biosystems LLC
NameRoleNamed in
David AndersonExecutive officerJul 2021
Paul PaganoExecutive officerJul 2021
Paul AndersonExecutive officerJul 2021
Michael PfauSecretaryMay 2021
Sara BarringtonChief Executive Officer and Chief Financial OfficerMar 2020
Simon RaabChairman of the BoardMar 2020
Scott BogartChief Financial OfficerOct 2019
Andre de FuscoChief Executive OfficerJun 2015
Michael de PfauSecretaryJun 2015
Andre De FuscoChief Executive OfficerSep 2014
Paul MeyerChief Financial OfficerNov 2012
Andre FuscoPresidentMay 2011
Michael E. PfauSecretaryJan 2010
Andrew Roy BotelerDirectorJul 2021
David AndersonDirectorJul 2021
Gordon Roy DavisDirectorJul 2021
James McCulloughDirectorJul 2021
Paul PaganoDirectorJul 2021
Sara Roy BarringtonDirectorJul 2021
Paul AndersonDirectorJul 2021
Frederick GluckDirectorMay 2021
Jianing LiuDirectorMay 2021
Justin XiangDirectorMay 2021
Simon RaabDirectorMay 2021
Dennis StuffblefieDirectorMar 2020
Jeffrey KobDirectorMar 2020
Sara BarringtonChief Executive Officer and Chief Financial OfficerMar 2020
Daotian FuDirectorSep 2019
Paul BillingsDirectorJan 2019
Alan de HeegerDirectorJun 2015
Andre de FuscoChief Executive OfficerJun 2015
Daotian de Fu, Ph.DDirectorJun 2015
Frederick de GluckDirectorJun 2015
Paul de BillingsDirectorJun 2015
Simon de RaabDirectorJun 2015
YuCai de Peng, Ph.DDirectorJun 2015
Alan HeegerDirectorSep 2014
Andre De FuscoChief Executive OfficerSep 2014
Tom Hyongsok SohDirectorSep 2014
Amit MunshiDirectorJan 2014